Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025)

Neurogene (NGNE) posted Asset Utilization Ratio of 0.0 for Q2 2025, down 18.41% on a QoQ basis from 0.0 in Q4 2024, and down 38.76% year-over-year from 0.0 in Q2 2024.

Neurogene (NGNE) Asset Utilization Ratio (2019 - 2025) Analysis & Trends

Neurogene's Asset Utilization Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q2 2025.

  • Quarterly Asset Utilization Ratio fell 38.76% year-over-year to 0.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.0 (down 38.76% YoY) and the FY2024 annual result came in at 0.0, changed N/A from the prior year.
  • Asset Utilization Ratio was 0.0 for Q2 2025 at Neurogene, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 10.89 in Q3 2023 and bottomed at 0.0 in Q2 2025.
  • A 3-year average of 3.96 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
  • Annual changes were most pronounced in 2024 — Asset Utilization Ratio slumped 99.95% — and 2025, when it tumbled 38.76%.
  • Neurogene's Asset Utilization Ratio stood at 6.41 in 2023, then plunged by 99.94% to 0.0 in 2024, then decreased by 18.41% to 0.0 in 2025.
  • Business Quant data shows NGNE's Asset Utilization Ratio at 0.0 in Q2 2025, 0.0 in Q4 2024, and 0.01 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Neurogene 17.50 Mn 17.50 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.01
Jun 30, 2024 0.00
Dec 31, 2023 6.41
Sep 30, 2023 10.89
Jun 30, 2023 10.39
Sep 30, 2019 14.28